Evidence map›Paper›PMID 38280018›Full record

ArticleAnalytical and bioanalytical chemistry2024

Improved sensitivity and automation of a multi-step upconversion lateral flow immunoassay using a 3D-printed actuation mechanism.

Kirsti Raiko, Oskari Nääjärvi, Miikka Ekman, Sonja Koskela, Tero Soukka, Iida Martiskainen, Teppo Salminen

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Lateral Flow Immunosensing ofMicroorganisms · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kirsti RaikoBiotechnology Unit, Department of Life Technologies, Faculty of Technology, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland. kisrai@utu.fi.
Oskari NääjärviBiotechnology Unit, Department of Life Technologies, Faculty of Technology, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Miikka EkmanBiotechnology Unit, Department of Life Technologies, Faculty of Technology, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Sonja KoskelaBiotechnology Unit, Department of Life Technologies, Faculty of Technology, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Tero SoukkaBiotechnology Unit, Department of Life Technologies, Faculty of Technology, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Iida MartiskainenBiotechnology Unit, Department of Life Technologies, Faculty of Technology, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Teppo SalminenBiotechnology Unit, Department of Life Technologies, Faculty of Technology, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
University of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of sensitive point-of-care (POC) assay platforms is of interest for reducing the cost and time of diagnostics. Lateral flow assays (LFAs) are the gold standard for POC systems, but their sensitivity as such is inadequate, for example, in the case of cardiac diagnostics. The performance can be improved by incorporating different steps, such as pre-incubation to prolong the interaction time between sample and reporter for immunocomplex formation, and washing steps for background reduction. However, for POC assays, manual steps by the assay conductor are not desired. In this research, upconverting nanoparticles (UCNPs) were coated with poly(acrylic acid) (PAA) and conjugated to anti-cTnI antibodies, yielding non-clustering particles with low non-specific binding. The performance of cTnI-LFA in the PAA-anti-cTnI-UCNPs was compared to the same UCNPs with a commercial carboxyl surface. A kitchen-timer mechanism was embedded in a 3D-printed housing to produce a low-cost actuator facilitating a timed pre-incubation step for reporter and sample, and a washing step, to enable a multi-step cTnI-LFA with minimized manual labour. PAA-UCNPs showed improved mobility on nitrocellulose compared to those with a commercial surface. The mechanical actuator system was shown to improve sensitivity compared to a labour-intensive multi-step dipstick method, despite pre-incubation occurring during shaking and heating in the dipstick method. The limit of detection decreased from 7.6 to 1.5 ng/L cTnI in human plasma. The presented actuator can be easily modified for sensitivity improvement in the LFA for different analytes via pre-incubation and washing steps.

Indexed as

NanoparticlesAutomationHumansImmunoassayPoint-of-Care SystemsPrinting, Three-DimensionalTroponin ITroponin IBioassaysBiomedical analysisLuminescenceNanoparticlesPolymersRare earth elements

Identifiers

PMID38280018
PMCPMC10861389
OpenAlexW4391275874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.